Most Popular posts from other blogs...
Drug Data Delay Offers Actelion Ltd. (ALIOF.PK) Bid Shield
2/16/2011
ZURICH, Feb 16 (Reuters) - Actelion (ATLN.VX), Europe's biggest biotech group, could be immune from takeover until the end of the year when data on a key heart and lung drug is due.
|
0 comments:
Post a Comment